Recombinant ErbB2/Her2 (Pertuzumab Biosimilar) anticorps
Aperçu rapide pour Recombinant ErbB2/Her2 (Pertuzumab Biosimilar) anticorps (ABIN7200658)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Fonction
- Pertuzumab Biosimilar, Human HER2 Monoclonal Antibody
-
Specificité
- The monoclonal antibody pertuzumab biosimilar specifically binds to the human HER2/ErbB-2/c-neu.
-
Attributs du produit
- Pertuzumab, a humanized monoclonal antibody, inhibits HER dimerization and is used for the treatment of HER2-positive metastatic breast cancer, in combination with trastuzumab and docetaxel. By binding to HER2, Pertuzumab inhibits the dimerization of HER2 with other HER receptors, resulting in slowed tumor growth.
-
Purification
- Protein A or G affinity column
-
Pureté
- >95 % by reducing SDS-PAGE
-
Stérilité
- 0.2 μm filtered
-
niveau d'endotoxine
- < 1 EU per 1 mg of the protein by the LAL method
-
Immunogène
- The monoclonal antibody pertuzumab biosimilar was produced in the pertuzumab biosimilar CHO stable cell line.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by pertuzumab.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- > 3 mg/mL
-
Buffer
- PBS, pH 7.4, no stabilizers or preservatives.
-
Agent conservateur
- Without preservative
-
Stock
- 4°C,-20 °C
-
Stockage commentaire
- 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
-
Date de péremption
- 12 months
-
-
- ErbB2/Her2 (Pertuzumab Biosimilar)
-
Autre désignation
- Pertuzumab Biosimilar
-
Classe de substances
- Biosimilar
Antigène
-